AI assistant
Navamedic — Share Issue/Capital Change 2021
Jan 18, 2021
3668_rns_2021-01-18_f1283b23-a002-42bf-b2d0-d78dcae621a2.html
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Navamedic ASA – Registration of share capital increase
Navamedic ASA – Registration of share capital increase
Oslo, 18 January 2021: Reference is made to Navamedic ASA's ("Navamedic" or the "Company") stock exchange announcement published on 4 January 2021 regarding the board of director's resolution to increase the Company's share capital in connection with the settlement of tranche 1 of the purchase price by issuing consideration shares for the acquisition of marketing authorisations for a series of antibiotics for hospital use in the Nordic region from ACS Dobfar and InfoRLife.
The share capital increase pertaining to the 1,053,775 consideration shares has now been registered with the Norwegian Register of Business Enterprises (Nw. Foretaksregisteret). The new share capital of the Company is 12,095,788.40, divided into 16,345,660 shares, each with a par value of NOK 0.74.
Following the registration of the new shares in the Norwegian Central Securities Depository (the VPS), which is expected to take place today, the new shares will be delivered to the subscriber and listed on the Oslo Stock Exchange.
For further information, please contact:
Kathrine Gamborg Andreassen, CEO, Navamedic
Mobile: +47 951 78 680
E-mail: [email protected]
Lars Hjarrand, CFO, Navamedic
Mobile: +47 917 62 842
E-mail: [email protected]
About Navamedic
Navamedic ASA is a full-service provider of high-quality healthcare products to hospitals and pharmacies. Navamedic meets the specific medical needs of patients and consumers by leveraging its highly scalable market access platform, leading category competence and local knowledge. Navamedic is present in all the Nordic countries, the Baltics and Benelux, with sales representation in the UK and Greece. Navamedic is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (ticker: NAVA). For more information, please visit www.navamedic.com
This information is subject to the disclosure requirements pursuant to the issuer rules for Oslo Børs.